FDA 483 - Baxter Oncology GmbH

During an inspection of Baxter Oncology GmbH, a drug and biologics manufacturer in Halle/Westfalen, Germany, the FDA observed a deficiency related to product compatibility testing. Specifically, the firm failed to perform testing to ensure the compatibility of bottle stopper material with other materials. This indicates a potential issue with quality control processes.